Why Farbe Firma is the Top Manufacturer of Acetaminophen and Ibuprofen Injection
- Maulik Sudani
- 1 day ago
- 10 min read
Last Updated: July 6, 2026
TL;DR: Acetaminophen and Ibuprofen Injection - a sterile, ready-to-use aqueous solution that combines two well-established analgesics in one container: acetaminophen (paracetamol), a centrally acting analgesic and antipyretic, and ibuprofen, a propionic-acid non-steroidal anti-inflammatory drug (NSAID) that blocks cyclo-oxygenase, supplied commonly as 1000 mg of acetaminophen with 300 mg of ibuprofen in a 100 mL intravenous infusion for the short-term treatment of acute pain and fever - is the fixed-dose combination hospitals use for multimodal, opioid-sparing analgesia after surgery and injury. Because two active ingredients with very different chemistry share one solution given straight into a vein, each container must deliver a sterile, correctly dual-potent, clear solution held at the right pH, with the acetaminophen and ibuprofen assays and their impurities, the antioxidant that protects the oxidation-prone paracetamol, solution pH, colour and clarity, osmolality, particulate and a low endotoxin level, a validated sterilisation route and verified container-closure integrity all mattering to potency and safety. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Acetaminophen and Ibuprofen Injection at our Gujarat, India facility and supplies it to hospital, surgical, anaesthesia and pain-management services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Fixed-dose combination analgesic - Acetaminophen and Ibuprofen Injection pairs acetaminophen (paracetamol), a centrally acting analgesic and antipyretic, with ibuprofen, a propionic-acid NSAID that inhibits cyclo-oxygenase and the prostaglandins that drive pain and inflammation; the two act by complementary mechanisms for multimodal, opioid-sparing pain relief, and the ready-to-use intravenous solution (commonly 1000 mg acetaminophen with 300 mg ibuprofen per 100 mL) demands a correctly dual-potent, clear, particulate-free solution in every container.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated compounding and filling, control of the acetaminophen and ibuprofen assays and their related substances by HPLC, antioxidant and pH control to protect the oxidation-prone paracetamol, osmolality, colour and clarity, particulate and endotoxin, validated terminal moist-heat sterilisation under inert-gas protection, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, combination-assay and related-substance data for both actives, sterilisation and container-closure data, forced-degradation data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile ready-to-use combination-analgesic infusion contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets with maximum-daily-dose and NSAID-caution guidance, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why the Right Acetaminophen and Ibuprofen Injection Manufacturer Matters
Acetaminophen and Ibuprofen Injection reflects a clear direction in modern pain management: combine two proven, non-opioid analgesics that work by different mechanisms so that each can be used at a measured dose while together they deliver strong, multimodal relief. It is the product an anaesthetist or surgical team reaches for to control acute moderate pain after an operation or injury, and to bring down fever, while reducing the amount of opioid a patient needs. Acetaminophen, known as paracetamol in much of the world, is a centrally acting analgesic and antipyretic whose exact mechanism is still being defined but which is not a classical anti-inflammatory. Ibuprofen is a propionic-acid non-steroidal anti-inflammatory drug that blocks the cyclo-oxygenase enzymes and the prostaglandins that drive pain, inflammation and fever at the site of tissue injury. Giving the two together intravenously combines a central and a peripheral mechanism in a single ready-to-use container, which is convenient in the operating theatre and recovery ward and supports opioid-sparing protocols. What makes the parenteral combination distinctive is that two active ingredients with very different physical chemistry - one oxidation-prone, one poorly water-soluble - have to coexist as a single stable, sterile solution, so the prescriber depends on a container in which both drugs are exactly potent.
That clinical reality places real demands on the manufacturer. Acetaminophen and Ibuprofen Injection is presented as a ready-to-use sterile aqueous solution, most commonly 1000 mg of acetaminophen with 300 mg of ibuprofen in a 100 mL infusion given intravenously over about fifteen minutes, so there is no reconstitution or dilution at the bedside and the labelled content of each active must be exact. The two actives set two different formulation problems that must be solved at once. Acetaminophen in water is prone to oxidation and hydrolysis - it can degrade to 4-aminophenol and discolour the solution to pink or brown - so the formulation needs an antioxidant, a carefully chosen pH, a nitrogen blanket and a low-oxygen headspace to keep it stable. Ibuprofen is a poorly water-soluble weak acid, so it has to be brought and held in solution, typically as a solubilised salt formed in situ with an amino base and a controlled pH, without pushing the pH to a point that harms the paracetamol. The solution must be clear and colourless to very pale, essentially isotonic and comfortable to infuse, held at a defined pH, and free of visible and sub-visible particulate. Because both actives are heat-tolerant when properly formulated and protected from oxygen, the filled containers are generally terminally sterilised by a validated moist-heat cycle under inert-gas protection, with bacterial endotoxin held very low and container-closure integrity assured. Choosing an Acetaminophen and Ibuprofen Injection manufacturer that treats the dual-active assay, oxidation control and validated sterilisation as core disciplines is what protects the patient at the point of care.
What Sets a World-Class Acetaminophen and Ibuprofen Injection Manufacturer Apart
A world-class manufacturer of Acetaminophen and Ibuprofen Injection invests in three areas that weaker suppliers underfund: precise, validated control of both the acetaminophen and the ibuprofen assay and their related substances by HPLC - confirming that each of the two actives is delivered at its labelled strength and that impurities such as paracetamol's 4-aminophenol are held to tight limits; disciplined antioxidant, pH and dissolved-oxygen control, because an oxidation-prone paracetamol and a poorly soluble ibuprofen have to stay stable and in solution together; and tender-ready dossier support, including the combination-assay, sterilisation and stability data, for a hospital analgesic procured through surgical, anaesthesia and ministry-of-health channels. It starts with the raw materials - pharmacopoeial acetaminophen and ibuprofen of controlled purity and impurity profile, the amino base used to solubilise the ibuprofen, the antioxidant and pH modifiers - each sourced from qualified, audited suppliers with full certificates of analysis verified by the receiving laboratory before the material enters production. Because the value of the product is a precise, stable, fully dual-potent, sterile dose of two analgesics in one container, the two assays, the impurity profile, the endotoxin and the sterility assurance are treated as central evidence rather than supporting annexes.
Compounding and filling then have to build - and defend - a correctly dual-potent, clear, stable combination solution. The ibuprofen is brought into solution with its amino base at a controlled pH while the acetaminophen is dissolved and immediately protected: the water for injection is deaerated, the antioxidant incorporated, the pH set into a window that keeps both actives stable and in solution, and the whole compounding and filling operation carried out under a nitrogen blanket to hold dissolved and headspace oxygen low. The solution is polished by filtration to remove particulate, passed through a sterilising-grade filter and filled into glass vials or infusion containers under ISO Class 5 conditions, the containers sealed under nitrogen and then terminally sterilised by a validated moist-heat cycle locked into the master batch record, giving a robust sterility assurance level for the aqueous solution. Filled units are 100% inspected for fill, seal, clarity, colour and particulate; in-process and release testing confirm the acetaminophen and ibuprofen assays and their related substances by HPLC, solution pH, colour and clarity against defined limits, the antioxidant content, the dissolved-oxygen level, osmolality, visible and sub-visible particulate matter, the deliverable volume, and that endotoxin is held well within limits so the solution is safe for intravenous infusion. Because the product is a potency-critical combination with an oxidation-prone active, the two assays and the impurity profile are confirmed before and after the sterilisation cycle, so the solution that leaves the plant is the same fully potent, clear, in-specification combination the specification requires - delivering both labelled doses with no loss of potency and no out-of-limit degradation in the container across shelf life.
Quality Systems Behind Every Acetaminophen and Ibuprofen Injection
Every Farbe Firma Acetaminophen and Ibuprofen Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of both acetaminophen and ibuprofen against reference standards with confirmation of the delivered milligrams of each, control of related substances including paracetamol's 4-aminophenol, solution pH, colour and clarity of solution against defined limits, antioxidant content, dissolved-oxygen level, osmolality, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the glass vial or infusion container. Certificates of analysis are issued with full traceability back to each acetaminophen and ibuprofen lot, the primary-packaging lot and the qualified person responsible for release. Because the product is a terminally sterilised combination whose clinical value depends on both actives arriving fully potent, the two assays and the impurity profile are qualified both before and after the sterilisation cycle so the combination's stability to heat is demonstrated rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated terminal-sterilisation and filling equipment with 100% inspection, sterilising-grade filtration with filter-integrity testing, nitrogen-protected compounding and filling to safeguard the oxidation-prone paracetamol, dedicated handling with cleaning validation, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because a ready-to-use analgesic given intravenously to post-surgical patients must deliver the full labelled dose of both actives while keeping endotoxin very low, we treat the two assays, the related-substance profile, the dissolved oxygen, the antioxidant content and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated conditions, with both assays and the impurity profile followed across the study, so the solution stays fully potent and within specification across the labelled shelf life, and the storage instructions on the label are supported by real data.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Acetaminophen and Ibuprofen Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad pain-management, analgesic and critical-care portfolio. For Acetaminophen and Ibuprofen Injection specifically, we supply the ready-to-use combination analgesic commonly as 1000 mg of acetaminophen with 300 mg of ibuprofen in a 100 mL intravenous infusion, under WHO-GMP conditions, with country-specific fill volumes and strengths, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the dual-assay, related-substance, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Acetaminophen and Ibuprofen Injection can request the two assays, the impurity profile and accelerated-stability summaries up front, which is often the deciding technical evidence for a combination analgesic in hospital-formulary and ministry-of-health review, since it is the confirmed potency of both actives and a validated sterility assurance that separate a dependable combination from an unreliable one.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability data, forced-degradation packages, sterilisation and container-closure reports, and translated package inserts and artwork - including the recommended infusion instructions, the maximum-daily-dose limits for each active, and the NSAID cautions on gastrointestinal, renal and cardiovascular risk together with the paracetamol overdose warning - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Acetaminophen and Ibuprofen Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the analgesic compounding, filling and sterilisation suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through acetaminophen and ibuprofen sourcing and impurity control, the design of a stable combination in which the oxidation-prone paracetamol is protected by antioxidant, pH and nitrogen control while the poorly soluble ibuprofen is held in solution, the dual-active assay strategy by HPLC, the validation of the terminal moist-heat sterilisation cycle under inert-gas protection, dissolved-oxygen and endotoxin control, colour, clarity and particulate control, fill and potency accuracy, container-closure integrity and shelf-life choices in real detail. For a combination analgesic where the potency of both actives, oxidation control and sterility directly govern efficacy and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Acetaminophen and Ibuprofen Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Acetaminophen and Ibuprofen Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, dedicated compounding and filling, nitrogen-protected processing, sterilising-grade filtration, validated terminal moist-heat sterilisation, 100% inspection and continuous environmental monitoring.
Which strengths and presentations of Acetaminophen and Ibuprofen Injection do you supply?
Our ready-to-use combination analgesic is available commonly as 1000 mg of acetaminophen with 300 mg of ibuprofen in a 100 mL intravenous infusion, given over about fifteen minutes with no reconstitution or dilution required. Custom strengths, fill volumes, vial and infusion-container formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Acetaminophen and Ibuprofen Injection mainly used for?
Acetaminophen and Ibuprofen Injection is used for the short-term treatment of acute moderate pain and for the reduction of fever, particularly after surgery or injury, where its two complementary non-opioid mechanisms support multimodal, opioid-sparing analgesia. Acetaminophen (paracetamol) is a centrally acting analgesic and antipyretic and ibuprofen is a propionic-acid NSAID; the combination carries the usual NSAID cautions on gastrointestinal, renal and cardiovascular risk and the paracetamol maximum-daily-dose limit. Farbe Firma verifies both assays, the impurity profile, pH, particulate matter and endotoxin at release so each container delivers a fully potent, sterile solution.
Can Farbe Firma support country-specific registrations for Acetaminophen and Ibuprofen Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability data, combination-assay, related-substance and forced-degradation packages, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Acetaminophen and Ibuprofen Injection contract manufacturing?
MOQs vary by strength, fill volume, vial or infusion-container format, label complexity and dossier requirements. For our ready-to-use infusion presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments